Lyons Kelly E, Pahwa Rajesh
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
CNS Drugs. 2008;22(12):1037-45. doi: 10.2165/0023210-200822120-00006.
Essential tremor is one of the most common movement disorders, yet the pharmacological treatments currently available have limited efficacy, being effective in only approximately 50% of patients with this disorder. The most commonly used, and generally most effective, medications for essential tremor are propranolol and primidone, administered either as monotherapy or in combination. If these medications do not provide satisfactory control of tremor, other beta-adrenoceptor antagonists, such as metoprolol or atenolol, and other antiepileptic drugs, such as topiramate or gabapentin, are often tried. In addition, benzodiazepines can be effective in some patients, particularly those with associated anxiety. There is a need for additional medications that result in greater tremor control in a larger number of patients with essential tremor. Several new drugs, including 1-octanol, sodium oxybate, dimethoxymethyl-diphenyl-barbituric acid (T-2000) and carisbamate, are currently under investigation for the treatment of essential tremor.
特发性震颤是最常见的运动障碍之一,然而目前可用的药物治疗效果有限,仅对约50%的该疾病患者有效。治疗特发性震颤最常用且通常最有效的药物是普萘洛尔和扑米酮,可单药治疗或联合使用。如果这些药物不能令人满意地控制震颤,常尝试使用其他β-肾上腺素能受体拮抗剂,如美托洛尔或阿替洛尔,以及其他抗癫痫药物,如托吡酯或加巴喷丁。此外,苯二氮䓬类药物对某些患者可能有效,尤其是伴有焦虑的患者。需要有更多药物能使更多特发性震颤患者的震颤得到更好控制。目前有几种新药正在研究用于治疗特发性震颤,包括1-辛醇、羟丁酸钠、二甲氧基甲基-二苯基-巴比妥酸(T-2000)和卡立普多。